FOREIGNIZATION AND DOMESTICATION IN THE MINISTERIAL WEBSITE LOCALIZATION

Autor: Ely Hayati Nasution, Roswita Silalahi, Vivi Adryani Nasution

Publikováno v: Journal of Applied Linguistics and Literature, Vol 4, Iss 2, Pp 136-145 (2019)

The translation is a representation of the effect of developing technology on language. Translated website or website localization with the easiness of accessibility is considered as the most efficient space for transferring the information nowadays.

Externí odkaz: https://doaj.org/article/28ba7f6504314075af825e9531178e98

DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome.

Autor: Juratli TA; Translational Neuro-Oncology Laboratory, Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Divisions of Hematology/Oncology and Neuro-Oncology, Departments of Medicine and Neurology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA.; Department of Neurosurgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., McCabe D; Joint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, 02215, USA.; Broad Institute of Harvard and MIT, 415 Main Street, Cambridge, MA, 02142, USA., Nayyar N; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Divisions of Hematology/Oncology and Neuro-Oncology, Departments of Medicine and Neurology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA., Williams EA; Translational Neuro-Oncology Laboratory, Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Silverman IM; Ignyta, Inc, San Diego, CA, USA., Tummala SS; Translational Neuro-Oncology Laboratory, Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Fink AL; Translational Neuro-Oncology Laboratory, Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Baig A; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Martinez-Lage M; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Selig MK; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Bihun IV; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Divisions of Hematology/Oncology and Neuro-Oncology, Departments of Medicine and Neurology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA., Shankar GM; Translational Neuro-Oncology Laboratory, Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Penson T; Translational Neuro-Oncology Laboratory, Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Lastrapes M; Joint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, 02215, USA.; Broad Institute of Harvard and MIT, 415 Main Street, Cambridge, MA, 02142, USA., Daubner D; Institute of Neuroradiology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Meinhardt M; Institute of Pathology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Hennig S; Department of Neurosurgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Kaplan AB; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Divisions of Hematology/Oncology and Neuro-Oncology, Departments of Medicine and Neurology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA., Fujio S; Translational Neuro-Oncology Laboratory, Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Kuter BM; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Divisions of Hematology/Oncology and Neuro-Oncology, Departments of Medicine and Neurology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA., Bertalan MS; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Divisions of Hematology/Oncology and Neuro-Oncology, Departments of Medicine and Neurology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA., Miller JJ; Translational Neuro-Oncology Laboratory, Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Batten JM; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Ely HA; Ignyta, Inc, San Diego, CA, USA., Christiansen J; Ignyta, Inc, San Diego, CA, USA., Baretton GB; Institute of Pathology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Stemmer-Rachamimov AO; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Santagata S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Rivera MN; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Barker FG 2nd; Translational Neuro-Oncology Laboratory, Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Schackert G; Department of Neurosurgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Wakimoto H; Translational Neuro-Oncology Laboratory, Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Iafrate AJ; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Carter SL; Joint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, 02215, USA.; Broad Institute of Harvard and MIT, 415 Main Street, Cambridge, MA, 02142, USA., Cahill DP; Translational Neuro-Oncology Laboratory, Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Brastianos PK; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Divisions of Hematology/Oncology and Neuro-Oncology, Departments of Medicine and Neurology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA. PBRASTIANOS@mgh.harvard.edu.

Publikováno v: Acta neuropathologica [Acta Neuropathol] 2018 Nov; Vol. 136 (5), pp. 779-792. Date of Electronic Publication: 2018 Aug 19.

Detecting Gene Rearrangements in Patient Populations Through a 2-Step Diagnostic Test Comprised of Rapid IHC Enrichment Followed by Sensitive Next-Generation Sequencing.

Autor: Murphy DA; Ignyta Inc., San Diego, CA †ArcherDX Inc., Boulder, CO ‡Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnamgu, Seoul, Korea., Ely HA, Shoemaker R, Boomer A, Culver BP, Hoskins I, Haimes JD, Walters RD, Fernandez D, Stahl JA, Lee J, Kim KM, Lamoureux J, Christiansen J

Publikováno v: Applied immunohistochemistry & molecular morphology : AIMM [Appl Immunohistochem Mol Morphol] 2017 Aug; Vol. 25 (7), pp. 513-523.

p38 mitogen-activated protein kinase is critical for synergistic induction of the FSH(beta) gene by gonadotropin-releasing hormone and activin through augmentation of c-Fos induction and Smad phosphorylation.

Autor: Coss D; Department of Reproductive Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093-0674, USA., Hand CM, Yaphockun KK, Ely HA, Mellon PL

Publikováno v: Molecular endocrinology (Baltimore, Md.) [Mol Endocrinol] 2007 Dec; Vol. 21 (12), pp. 3071-86. Date of Electronic Publication: 2007 Sep 06.